14-day Premium Trial Subscription Try For FreeTry Free
$0.0008
+0 (+0%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0007 $0.0026 Thursday, 2nd May 2024 PPCB stock ended at $0.0008. During the day the stock fluctuated 28.57% from a day low at $0.0007 to a day high of $0.0009.
90 days $0.0007 $0.0065
52 weeks $0.0001 $0.263

Historical Propanc Biopharma Inc prices

Date Open High Low Close Volume
Sep 27, 2023 $0.0259 $0.0280 $0.0220 $0.0248 407 962
Sep 26, 2023 $0.0280 $0.0288 $0.0232 $0.0287 284 683
Sep 25, 2023 $0.0288 $0.0288 $0.0250 $0.0267 53 754
Sep 22, 2023 $0.0270 $0.0290 $0.0237 $0.0270 253 462
Sep 21, 2023 $0.0242 $0.0300 $0.0220 $0.0270 552 722
Sep 20, 2023 $0.0271 $0.0300 $0.0242 $0.0269 147 557
Sep 19, 2023 $0.0291 $0.0320 $0.0250 $0.0250 225 942
Sep 18, 2023 $0.0320 $0.0360 $0.0295 $0.0295 143 514
Sep 15, 2023 $0.0390 $0.0390 $0.0285 $0.0300 290 087
Sep 14, 2023 $0.0295 $0.0300 $0.0282 $0.0300 203 402
Sep 13, 2023 $0.0333 $0.0333 $0.0273 $0.0287 247 787
Sep 12, 2023 $0.0360 $0.0390 $0.0300 $0.0300 346 270
Sep 11, 2023 $0.0399 $0.0399 $0.0300 $0.0300 341 322
Sep 08, 2023 $0.0350 $0.0400 $0.0300 $0.0355 319 916
Sep 07, 2023 $0.0390 $0.0390 $0.0280 $0.0350 774 225
Sep 06, 2023 $0.0396 $0.0410 $0.0376 $0.0399 267 876
Sep 05, 2023 $0.0495 $0.0495 $0.0396 $0.0424 450 323
Sep 01, 2023 $0.0500 $0.0625 $0.0430 $0.0430 208 830
Aug 31, 2023 $0.0600 $0.0700 $0.0410 $0.0549 305 708
Aug 30, 2023 $0.0600 $0.0800 $0.0502 $0.0600 454 315
Aug 29, 2023 $0.0608 $0.0608 $0.0520 $0.0600 75 687
Aug 28, 2023 $0.0400 $0.0640 $0.0330 $0.0600 863 849
Aug 25, 2023 $0.0380 $0.0420 $0.0300 $0.0327 63 538
Aug 24, 2023 $0.0395 $0.0395 $0.0281 $0.0300 358 972
Aug 23, 2023 $0.0338 $0.0400 $0.0325 $0.0350 343 171
Click to get the best stock tips daily for free!

About Propanc Biopharma Inc

Propanc Biopharma Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc... PPCB Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT